← Open Payments lookup

HECTOR GUILLEN: Open Payments

NPI 1891386942 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,252 in 175 payments from 13 companies in 2025. Trend: 2023 $1,434 · 2024 $2,456 · 2025 $3,252

Food & beverage: $3,252
CompanyPaymentsAmount
Alkermes, Inc.34$561
Otsuka America Pharmaceutical, Inc.27$448
ABBVIE INC.26$440
Corium, LLC20$425
Axsome Therapeutics, Inc.13$283
E.R. Squibb & Sons, L.L.C.12$271
Teva Pharmaceuticals USA, Inc.15$225
Takeda Pharmaceuticals U.S.A., Inc.8$188
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$107
Neurocrine BioSciences, Inc.5$100

Products named: REXULTI, VRAYLAR, Azstarys, ARISTADA, Auvelity, COBENFY, TRINTELLIX, LYBALVI.

Industry payments across TX — which companies pay providers there.